Cancer Therapy BNCT System

We exclusively represent the NeuCure BNCT system by Sumitomo Heavy Industries for the Canadian and European markets, offering full export support and clinical integration.

NeuCure™ BNCT System by Sumitomo Heavy Industries

NeuCure is Sumitomo Heavy Industries’ state-of-the-art BNCT (Boron Neutron Capture Therapy) system, designed to treat deep-seated or non-operable tumors with precision neutron beams.
Marsole is the exclusive export partner for NeuCure in Canada and the EU, supporting hospitals through clinical onboarding, licensing, and investor relations.

Key Highlights

• Developed by Japan’s leading heavy industry firm, Sumitomo

• Suitable for head & neck cancers, melanoma, and glioblastoma

• Minimally invasive, outpatient-based therapy

Protection of Critical Operations

We partner with government agencies and critical industries to deliver customized, mission-critical security technologies.
Through strategic collaboration, we enhance national and corporate resilience in the face of complex global challenges.

Strategic Vision & Export Expansion

Leveraging cutting-edge innovations, we deliver systems capable of detecting, managing, and neutralizing emerging risks across air, land, and digital domains.
Our solutions enable proactive protection against evolving threats, ensuring continuity and operational excellence.

Integrated Security Solutions for Government and Enterprise

We deliver specialized technology solutions designed to secure critical operations, protect sensitive environments, and support national resilience initiatives."

Global Partnership Invitation

Marsole is actively seeking regional distributors, hospital groups, and government procurement partners interested in Sumitomo’s BNCT and Samjung’s defense innovations